AXSPA

Clinical trials for AXSPA explained in plain language.

Never miss a new study

Get alerted when new AXSPA trials appear

Sign up with your email to follow new studies for AXSPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug SPY002-072 aims to tame multiple inflammatory joint diseases

Disease control Ongoing

This Phase 2 study tests an experimental drug called SPY002-072 in 285 adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. Participants receive either the drug or a placebo, and researchers measure changes in disease ac…

Matched conditions: AXSPA

Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

AXSPA

Get alerted when new AXSPA trials appear

New drug SPY002-072 aims to tame multiple inflammatory joint diseases